Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-10-010939
Filing Date
2010-03-01
Accepted
2010-03-01 17:13:50
Documents
13
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a09-34643_210k.htm 10-K 2775380
2 EX-10.6 a09-34643_2ex10d6.htm EX-10.6 542817
3 EX-10.13 a09-34643_2ex10d13.htm EX-10.13 284161
4 EX-10.35 a09-34643_2ex10d35.htm EX-10.35 25246
5 EX-10.45 a09-34643_2ex10d45.htm EX-10.45 50135
6 EX-21.1 a09-34643_2ex21d1.htm EX-21.1 2562
7 EX-23.1 a09-34643_2ex23d1.htm EX-23.1 3621
8 EX-31.1 a09-34643_2ex31d1.htm EX-31.1 12522
9 EX-31.2 a09-34643_2ex31d2.htm EX-31.2 12551
10 EX-32.1 a09-34643_2ex32d1.htm EX-32.1 7618
11 GRAPHIC g346432ba09i001.gif GRAPHIC 8530
12 GRAPHIC g346432ba03i001.gif GRAPHIC 30638
13 GRAPHIC g346432ba03i002.gif GRAPHIC 18814
  Complete submission text file 0001104659-10-010939.txt   3798351
Mailing Address 1896 RUTHERFORD ROAD CARLSBAD CA 92008
Business Address 1896 RUTHERFORD ROAD CARLSBAD CA 92008 7609319200
ISIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19125 | Film No.: 10645752
SIC: 2834 Pharmaceutical Preparations